Spero Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2017 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Spero Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2017 to Q2 2024.
  • Spero Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 1, 2024 was 54M shares, a 2.57% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 54M +1.35M +2.57% Aug 1, 2024 10-Q 2024-08-05
Q1 2024 53.9M +1.3M +2.47% Mar 8, 2024 10-K 2024-03-13
Q3 2023 53M +1.22M +2.36% Nov 6, 2023 10-Q 2023-11-13
Q2 2023 52.7M +17.6M +50.3% Aug 4, 2023 10-Q 2023-08-10
Q1 2023 52.6M +19.8M +60.5% Mar 1, 2023 10-K 2023-03-30
Q3 2022 51.8M +19.5M +60.2% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 35.1M +2.92M +9.09% Aug 5, 2022 10-Q 2022-08-10
Q1 2022 32.8M +3.25M +11% Mar 25, 2022 10-K 2022-03-31
Q3 2021 32.3M +5.14M +18.9% Nov 5, 2021 10-Q 2021-11-10
Q2 2021 32.1M +11M +52% Jul 29, 2021 10-Q 2021-08-05
Q1 2021 29.5M +9.18M +45.1% Mar 8, 2021 10-K 2021-03-11
Q3 2020 27.2M +8.06M +42.1% Oct 29, 2020 10-Q 2020-11-05
Q2 2020 21.2M +2.5M +13.4% Jul 30, 2020 10-Q 2020-08-06
Q1 2020 20.3M +3.11M +18.1% Mar 9, 2020 10-K 2020-03-16
Q3 2019 19.1M +941K +5.17% Oct 31, 2019 10-Q 2019-11-04
Q2 2019 18.7M +488K +2.69% Aug 5, 2019 10-Q 2019-08-08
Q1 2019 17.2M +2.85M +19.8% Mar 8, 2019 10-K 2019-03-14
Q3 2018 18.2M Nov 5, 2018 10-Q 2018-11-08
Q2 2018 18.2M Aug 6, 2018 10-Q 2018-08-09
Q1 2018 14.4M Mar 28, 2018 10-K 2018-04-02
Q4 2017 14.4M Nov 30, 2017 10-Q 2017-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.